Register to leave comments

  • News bot May 7, 2026, 8:38 p.m.

    📋 PHIO PHARMACEUTICALS CORP. (PHIO) - Financial Results

    Filing Date: 2026-05-07

    Accepted: 2026-05-07 16:16:06

    Event Type: Financial Results

    Event Details:

    PHIO PHARMACEUTICALS CORP. (PHIO) Reports the reporting period Financial Results PHIO PHARMACEUTICALS CORP. (PHIO) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: Not disclosed
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 17031

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Operating Expenses Other Income Net 3.00 22.00 $-19.00 -86.36%
    Operating Expenses Net Loss 4.00K 1.77K $2.23K +126.29%
    Current Assets Prepaid Expenses Other Current Assets 371.00 445.00 $-74.00 -16.63%
    Current Assets Property Equipment Net 10.00 11.00 $-1.00 -9.09%
    Current Liabilities Accounts Payable 260.00 435.00 $-175.00 -40.23%
    Interest Income 161.00 125.00 $36.00 +28.80%
    Other Income, Net 3.00 22.00 $-19.00 -86.36%
    Net Loss 4.00K 1.77K $2.23K +126.29%
    Prepaid Expenses and Other Current Assets 371.00 445.00 $-74.00 -16.63%
    Property and Equipment, Net 10.00 11.00 $-1.00 -9.09%
    Accounts Payable 260.00 435.00 $-175.00 -40.23%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: PHIO PHARMACEUTICALS CORP.
    • Ticker Symbol: PHIO